Skip to content
thestock.space

As of 6 Nov 2026, Genomic Valley Biotech is loss-making on a trailing 12-month basis, with a net loss of ₹0.00 Cr, so it has no P/E ratio. The share price is ₹55.53. Sales fell 54% a year over 3 years. It is a small-cap company with a market cap of ₹17 Cr, ranked 19th of 20 Biotechnology companies by market cap; the shares rose 64% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹61.37
Day high
₹61.37
Day low
₹55.53
Prev. close
₹58.45
Volume
43.8K

Health check

1 good · 1 fair · 4 to check
  • ReturnsAhead

    +64.3% over a year, better than 7 of 7 peers.

  • Price tagLoss-making

    Earnings were negative over the last 12 months.

  • GrowthShrinking

    Sales −53.8%, profit −64.0% a year over 3 years.

  • ProfitabilityWeak

    ROCE 1.0% vs peer median 16.7%.

  • Balance sheetFair

    Piotroski 4 of 9.

  • Red flags4 to check

    Loss-making over the last twelve months.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Biotechnology

19 listed peers. Screen the industry

Small cap

₹17 Cr, #19 of 20 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹0 Cr · profit ₹−0 Cr
Market cap
₹17 Cr
Small cap
P/E
925.5
Industry 49.1
Price to book
4.66
Peers 4.68
Dividend yield
0.00%
ROE
−0.1%
Peers 14.3%
ROCE
1.0%
Peers 16.7%
Debt to equity
n/a
Debt ₹0.00 Cr
EPS (TTM)
₹0.06
OPM (TTM)
25.5%
Net margin −2.2%
Sales growth
−57.8%
Latest quarter vs a year ago
Profit growth
−40.7%
Latest quarter vs a year ago
Price to sales
135.15
EV/EBITDA 1716.8

Strengths and risks

Risks to check

  • Loss-making over the last twelve months.
  • Return on equity is low at −0.1%.
  • Quarterly profit down 40.7% on a year ago.
  • Quarterly sales down 57.8% on a year ago.

No standout strengths in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Genomic Valley Biotech

Genomic Valley Biotech Limited operates in horticulture business activities in India. The company involved in the commercial greenhouse/poly house cultivation of crops; commercial horticulture activities with aloe vera, tomato, bitter gourd, bottle gourd, brinjal, broccoli, cabbage, capsicum, carrot, cauliflower, cucumber, green chilies, onion, radish, ridge/sponge gourd, leafy vegetables, pumpkin, banana, guava, papaya, and strawberry; and commercial…

Headquarters
Delhi
Sector
Healthcare
ISIN
INE574D01010
Website
genomicvalley.com

Price range

52 weeks

₹20.10₹61.37

Today

₹55.53₹61.37
Avg volume (3M)
2.3K
1-year return
plus 64.3%
From 52-week high
minus 9.5%

Peers · Biotechnology

Compare with peersScreen the whole industry
Company
BIOCONBiocon365.10plus 0.86%59,794122.51.732.8%1.0%19.4%15.3%−5.9%0.14%minus 4.9%
ANTHEMAnthem Biosciences915.55plus 0.22%51,59484.615.7426.8%20.4%41.4%26.2%15.4%0.22%plus 30.1%
ONESOURCEOnesource Specialty Pharma1,599.80plus 1.13%18,346–3.100.3%0.0%23.5%232.3%–0.00%minus 13.7%
CONCORDBIOConcord Biotech632.60minus 5.96%13,23647.46.4816.7%14.3%34.5%8.0%2.8%0.60%minus 7.5%
BLUEJETBlue Jet Healthcare553.80minus 3.91%9,60734.54.5224.0%19.9%31.4%9.4%15.7%0.22%minus 5.0%
SUPRIYASupriya Lifescience695.80minus 19.99%5,60028.24.6822.3%19.1%21.4%21.2%32.5%0.14%plus 9.2%
ZOTAZota Health Care1,231.10plus 1.01%4,264–6.82−7.3%−24.1%0.1%56.7%–0.08%minus 21.9%
GVBLGenomic Valley Biotech55.53minus 5.00%17925.54.661.0%−0.1%25.5%−53.8%−64.0%0.00%plus 64.3%
Median of 7 peers–0.22%13,23647.44.6816.7%14.3%23.5%21.2%15.4%0.14%−5.0%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrMar 25Jun 25Dec 25Mar 26Jun 26
0.30.10.100
–––minus 85.8%minus 57.8%
0.30.1000
00000
1.1%28.3%22.6%7.7%40.6%
000−00
00000
00000
4601.3%––623.2%–
−0.100−00
-0.270.080.03-0.030.05

Sep 25 not reported by the data source.

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
−53.8%
Profit CAGR 3Y
−64.0%
EPS CAGR 3Y
−63.9%
ROE
−0.1%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
2.70.20.80.3
–minus 93.9%+411.2%minus 68.3%
2.10.10.40.2
0.700.40
24.1%10.7%52.1%16.4%
0.3−00−0
00––
0000
−0.3−0––
0.600.40
0.1%−0.2%19.3%24.3%
0.600.40
–minus 97.7%+2245.5%minus 91.5%
2.120.051.170.10

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
3.13.13.13.1
0.50.50.80.9
0.90.80.50.3
4.44.34.44.2
1.41.40.90
1.41.40.9–
–0––
0000
1.61.52.54.2
4.44.34.44.2

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−0.8−00−0
1.5−00–
−0.7–––
0−00−0
––−0–
−0.8−00−0

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you